trial · primary record
BI 1831169
Solid Tumors
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 190 |
| Primary completion | 2028-10-31 |
| Primary endpoint | Part 1.1, Dose escalation/Confirmation: Occurrence of Dose limiting toxicities (DLTs) during the mono Maximum tolerated dose (MTD) evaluation period |
| Registry ID | NCT05155332 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:18.448Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05155332
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.